Alzheimer disease biomarker testing in cerebrospinal fluid: a method to harmonize assay platforms in the absence of an absolute reference standard.
Hugo Marcel
HM
Vanderstichele
Leslie
L
Shaw
Manu
M
Vandijck
Andreas
A
Jeromin
Henrik
H
Zetterberg
Kaj
K
Blennow
Charlotte
C
Teunissen
Sebastiaan
S
Engelborghs
D000544:Alzheimer Disease / Q000134:cerebrospinal fluid / Q000175:diagnosis*; D016229:Amyloid beta-Peptides / Q000134:cerebrospinal fluid*; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D010446:Peptide Fragments / Q000134:cerebrospinal fluid*; D012015:Reference Standards
D016229:Amyloid beta-Peptides; D010446:Peptide Fragments; C075222:amyloid beta-protein (1-42)